Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.

Autor: Fabregas JC; University of Florida Health Cancer Center, University of Florida, 1600 SW Archer Road, D2-3, Gainesville, FL, 32610, USA., Carter BT; Billings Clinic, 2800 Tenth Avenue North, Billings, MT, 59107, USA.; Collaborative Science & Innovation, 2800 Tenth Avenue North, Billings, MT, 59101, USA., Lutzky J; University of Miami - Sylvester Comprehensive Cancer Center, 1475 NW Ave, Floor 2, Miami, FL, 33136, USA., Robinson WR 3rd; Department of Obstetrics and Gynecology, University of Mississippi Medical Center, J2500 N State St, Jackson, MS, 39216, USA., Brant JM; Billings Clinic, 2800 Tenth Avenue North, Billings, MT, 59107, USA. jbrant@billingsclinic.org.

Publikováno v: Journal of racial and ethnic health disparities [J Racial Ethn Health Disparities] 2022 Dec; Vol. 9 (6), pp. 2291-2299. Date of Electronic Publication: 2021 Oct 14.

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.

Autor: Alvarez RD; The University of Alabama at Birmingham, Birmingham, AL, USA., Gray HJ, Timmins PF 3rd, Gibb RK, Edelson M, Fowler JM, Havrilesky LJ, McCauley DL, Nash JD, Rahaman J, Rash JK, Rodabaugh KJ, Powell MA, Bristow RE, Brown JV, Tewari D, Cliby WA, Anastasia P, Robinson WR 3rd, Shahin MS, Cantrell LA, Cloven NG, Gold MA, Hope JM, Muntz HG, Sorosky JI, Elkas JC, Frumovitz MM, Jewell E, Spillman MA, Naumann RW

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2013 Apr; Vol. 129 (1), pp. 3-4.

Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study.

Autor: Tiersten AD; New York University Cancer Center, New York, NY 10016, USA. amy.tiersten@nyumc.org, Moon J, Smith HO, Wilczynski SP, Robinson WR 3rd, Markman M, Alberts DS

Publikováno v: Oncology [Oncology] 2009; Vol. 77 (6), pp. 395-9. Date of Electronic Publication: 2010 Feb 02.

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study.

Autor: Lavey RS; University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA. rlavey@chla.usc.edu, Liu PY, Greer BE, Robinson WR 3rd, Chang PC, Wynn RB, Conrad ME, Jiang C, Markman M, Alberts DS

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2004 Oct; Vol. 95 (1), pp. 145-51.

Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.

Autor: Hetland, Thea, Kærn, Janne, Skrede, Martina, Sandstad, Berit, Tropé, Claes, Davidson, Ben, Flørenes, Vivi

Publikováno v: Cancer Chemotherapy & Pharmacology; May2012, Vol. 69 Issue 5, p1307-1314, 8p